Stock Overview

SBC Medical Group Holdings Incorporated (SBC)

NASDAQ · Industrials · Consulting Services

SBC Medical Group Holdings Incorporated is a Industrials company with a market capitalization of $338.50M and a trailing P/E ratio of 8.3.

Market Cap
$338.50M
P/E (TTM)
8.3
Forward P/E
7.0
Price/Sales
2.0
Price/Book
1.3
EV/EBITDA
3.0
Beta
0.59
EPS (TTM)
$0.40
Profit Margin
24.1%
ROE
16.5%
52W High
$5.75
52W Low
$2.78

5-Year Price History

Latest Annual Financials · FY ending December 31, 2025

Revenue
$173.61M
Gross Profit
$127.28M
Operating Income
$67.49M
Net Income
$50.99M
Free Cash Flow
$36.55M
Total Debt
$47.38M
Cash & Equivalents
$163.77M
Shareholder Equity
$248.28M

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q1 2026May 14, 2026$0.11$0.10+6.5%
Q4 2025March 27, 2026$0.14$0.11+27.3%
Q3 2025November 14, 2025$0.12$0.10+20.0%
Q2 2025August 13, 2025$0.02$0.14-85.7%
Q1 2025May 15, 2025$0.21$0.16+31.3%
Q4 2024March 28, 2025$0.06$0.19-68.4%

Other Consulting Services Stocks

Frequently Asked Questions

What is SBC Medical Group Holdings Incorporated's market cap?

As of June 29, 2026, SBC Medical Group Holdings Incorporated (SBC) has a market capitalization of $338.50M.

What is SBC Medical Group Holdings Incorporated's P/E ratio?

SBC Medical Group Holdings Incorporated trades at a trailing price-to-earnings (P/E) ratio of 8.3. Its forward P/E is 7.0.

Does SBC Medical Group Holdings Incorporated pay a dividend?

SBC Medical Group Holdings Incorporated does not currently pay a dividend.

What sector is SBC in?

SBC Medical Group Holdings Incorporated is in the Industrials sector, specifically the Consulting Services industry.

What was SBC Medical Group Holdings Incorporated's revenue?

In its latest reported fiscal year (ending December 31, 2025), SBC Medical Group Holdings Incorporated reported revenue of $173.61M and net income of $50.99M.

Ask your own questions about SBC

Try mrmarket.ai free

Data as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.